Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Non-Current Assets: 2021-2024

Historic Non-Current Assets for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $15,081.

  • ProQR Therapeutics N.V's Non-Current Assets fell 4.01% to $15,219 in Q3 2025 from the same period last year, while for Sep 2025 it was $15,219, marking a year-over-year decrease of 4.01%. This contributed to the annual value of $15,081 for FY2024, which is 17.49% down from last year.
  • As of FY2024, ProQR Therapeutics N.V's Non-Current Assets stood at $15,081, which was down 17.49% from $18,278 recorded in FY2023.
  • ProQR Therapeutics N.V's 5-year Non-Current Assets high stood at $21.4 million for FY2021, and its period low was $15,081 during FY2024.
  • For the 3-year period, ProQR Therapeutics N.V's Non-Current Assets averaged around $5.7 million, with its median value being $18,278 (2023).
  • Data for ProQR Therapeutics N.V's Non-Current Assets shows a maximum YoY plummeted of 99.89% (in 2023) over the last 5 years.
  • ProQR Therapeutics N.V's Non-Current Assets (Yearly) stood at $21.4 million in 2021, then decreased by 19.67% to $17.2 million in 2022, then tumbled by 99.89% to $18,278 in 2023, then fell by 17.49% to $15,081 in 2024.